◀ Back to SOCS3
SOCS1 — SOCS3
Pathways - manually collected, often from reviews:
-
BioCarta il-2 receptor beta chain in t cell activation:
SOCS3
→
SOCS1
(modification, inhibits)
-
BioCarta il-2 receptor beta chain in t cell activation:
SOCS3
→
SOCS1
(modification, inhibits)
-
BioCarta il-2 receptor beta chain in t cell activation:
SOCS3
→
SOCS1
(modification, inhibits)
-
BioCarta il-2 receptor beta chain in t cell activation:
SOCS3
→
SOCS1
(modification, inhibits)
-
NCI Pathway Database IL2-mediated signaling events:
IL2R gamma/JAK3/SOCS1 complex (IL2RG-JAK3-SOCS1)
→
IL2R beta/JAK1/LCK/SOCS3 complex (IL2RB-JAK1-LCK-SOCS3)
(modification, inhibits)
Delespine-Carmagnat et al., FEBS Lett 1999, Cohney et al., Mol Cell Biol 1999, Aman et al., J Biol Chem 1999, Takeshita et al., J Immunol 1992, Asao et al., FEBS Lett 1992, Takeshita et al., Science 1992, Arima et al., J Immunol 1991, Hatakeyama et al., Science 1991, Asao et al., J Exp Med 1990, Mills et al., J Biol Chem 1990, Hatakeyama et al., Cell 1989, Sharon et al., Science 1986, Goldsmith et al., J Biol Chem 1995, Boussiotis et al., Science 1994, Russell et al., Science 1994, Miyazaki et al., Science 1994, Beadling et al., EMBO J 1994, Rebollo et al., Immunology 1993, Lai et al., Proc Natl Acad Sci U S A 1996, Gaffen et al., J Biol Chem 1996, Endo et al., Nature 1997, Liu et al., Curr Biol 1997, Zhou et al., Proc Natl Acad Sci U S A 1997, Fujii et al., EMBO J 1998
Evidence: mutant phenotype, assay, reporter gene, physical interaction, other species
-
NCI Pathway Database IL2-mediated signaling events:
IL2R beta/JAK1/LCK/SOCS3 complex (IL2RB-JAK1-LCK-SOCS3)
→
IL2R beta/JAK1/LCK/SOCS1 complex (IL2RB-JAK1-LCK-SOCS1)
(modification, inhibits)
Delespine-Carmagnat et al., FEBS Lett 1999, Cohney et al., Mol Cell Biol 1999, Aman et al., J Biol Chem 1999, Takeshita et al., J Immunol 1992, Asao et al., FEBS Lett 1992, Takeshita et al., Science 1992, Arima et al., J Immunol 1991, Hatakeyama et al., Science 1991, Asao et al., J Exp Med 1990, Mills et al., J Biol Chem 1990, Hatakeyama et al., Cell 1989, Sharon et al., Science 1986, Goldsmith et al., J Biol Chem 1995, Boussiotis et al., Science 1994, Russell et al., Science 1994, Miyazaki et al., Science 1994, Beadling et al., EMBO J 1994, Rebollo et al., Immunology 1993, Lai et al., Proc Natl Acad Sci U S A 1996, Gaffen et al., J Biol Chem 1996, Endo et al., Nature 1997, Liu et al., Curr Biol 1997, Zhou et al., Proc Natl Acad Sci U S A 1997, Fujii et al., EMBO J 1998
Evidence: mutant phenotype, assay, reporter gene, physical interaction, other species
-
NCI Pathway Database IL2-mediated signaling events:
IL2R beta/JAK1/LCK/SOCS3 complex (IL2RB-JAK1-LCK-SOCS3)
→
IL2R beta/JAK1/LCK/SOCS1 complex (IL2RB-JAK1-LCK-SOCS1)
(modification, inhibits)
Cohney et al., Mol Cell Biol 1999, Aman et al., J Biol Chem 1999, Delespine-Carmagnat et al., Eur J Immunol 2000, Gilmour et al., Proc Natl Acad Sci U S A 1995, Gaffen et al., Proc Natl Acad Sci U S A 1995, Johnston et al., Proc Natl Acad Sci U S A 1995, Hou et al., Immunity 1995, Lin et al., Immunity 1995, Fujii et al., Proc Natl Acad Sci U S A 1995, Wakao et al., EMBO J 1995, Beadling et al., EMBO J 1994, Friedmann et al., Proc Natl Acad Sci U S A 1996, Gaffen et al., J Biol Chem 1996, Liu et al., Curr Biol 1997, Fujii et al., EMBO J 1998
Evidence: mutant phenotype, assay, reporter gene, physical interaction, other species
Text-mined interactions from Literome
Stark et al., J Neuroimmunol 2004
(Encephalomyelitis, Autoimmune, Experimental) :
Treatment with conditioned medium from myelin basic protein stimulated encephalitogenic lymphoid cells ( MBP-CM ) increased
SOCS-3 and
induced SOCS-1 expression
McGillicuddy et al., J Biol Chem 2009
(Insulin Resistance) :
IFNgamma induced robust STAT1 phosphorylation and
SOCS1 mRNA expression, with modest, transient STAT3 phosphorylation and
SOCS3 induction
Wada et al., Am J Physiol Endocrinol Metab 2011
(Insulin Resistance) :
IFN-ß preferentially
induced SOCS1 rather than SOCS3, whereas IFN-? strongly induced
SOCS3 expression alone
Park et al., J Allergy Clin Immunol 2013
(Nasal Polyps...) :
SOCS1 was
induced by IL-4, IL-13, IFN-?, and TNF-a, while
SOCS3 expression was upregulated by IL-6, IL-13, IFN-?, and TNF-a
Suzuki et al., Oncogene 1998
(Leukemia, Myeloid, Acute) :
In M1 myeloid leukemia cells,
CIS3 was
induced by neither interleukin 6 (IL6) nor interferon gamma (IFNgamma), while
JAB was induced strongly by IFNgamma and slightly by IL6 and leukemia inhibitory factor (ILF)